Related Experiment Video
Updated: Jul 7, 2026
07:45
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Targeting p38-MAPK in the ischaemic heart: kill or cure?
Rekha Bassi1, Richard Heads, Michael S Marber
1King College London, Department of Cardiology, Cardiovascular Division. Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK.
Current Opinion in Pharmacology
|February 22, 2008
Summary
The p38-MAPK pathway
Area of Science:
- Cardiovascular Biology
- Cell Signaling
Background:
- The p38-MAPK pathway is crucial in myocardial ischemia/reperfusion injury.
- It regulates key cardiac functions including gene expression, hypertrophy, inflammation, metabolism, contractility, proliferation, and apoptosis.
Purpose of the Study:
- To elucidate the precise mechanism of p38-MAPK activation during myocardial ischemia.
- To differentiate between detrimental and protective p38-MAPK activation pathways.
- To identify signaling molecules for targeted pharmaceutical intervention.
Main Methods:
- This study focuses on understanding the signaling mechanisms of p38-MAPK activation in the context of myocardial ischemia.
- Specific experimental approaches to dissect the pathway are implied but not detailed in the abstract.
Main Results:
- Dual phosphorylation of p38-MAPK during ischemia exacerbates lethal cardiac injury.
- Evidence suggests that p38-MAPK activation mechanisms vary depending on the specific cardiac circumstance.
- Detrimental and potentially beneficial roles of p38-MAPK activation are highlighted.
Conclusions:
- Understanding the specific activation mechanisms of p38-MAPK in ischemia is critical.
- Targeting detrimental p38-MAPK activation could prevent cardiac injury without compromising protective effects.
- This research may lead to novel therapeutic strategies for heart conditions.
